Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...
Combinatorial Analysis of Plasma and DNA Methylation Biomarkers in African American Patients with Multiple Sclerosis
Background: African American patients are at increased risk of developing severe forms of multiple sclerosis and have been underrepresented...
Passive Monitoring of Cognition Using a Smartphone Application in MS
Background: Cognitive impairment is one of the most common and debilitating symptoms of multiple sclerosis (MS). Traditional...
Mindfulness Based Art Therapy to Improve Symptoms Among Adults with Multiple Sclerosis
Background: Multiple sclerosis (MS) MS affects nearly one million people in the United States and more than two million worldwide. Symptoms...
Efficacy and Safety of Ublituximab Versus Teriflunomide in Relapsing Multiple Sclerosis: Results of the Phase 3 Ultimate I and II Trials
Background: Ublituximab, a novel monoclonal antibody, targets a unique epitope on the CD20 antigen and is glycoengineered for enhanced...
Frequency and Characteristics of Falls in People Living with and without Multiple Sclerosis during the COVID-19 Pandemic: An Online Survey
Background: Public health responses to Coronavirus Disease 2019 (COVID-19) including lockdowns may negatively impact physical and mental...